Single-cell transcriptomic profiling uncovers cellular diversity in pancreatic ductal adenocarcinoma, suggesting new therapeutic targets.
Single-cell RNA sequencing is a powerful approach for characterising cellular heterogeneity and elucidating transcriptional programs that drive tumour plasticity, therapeutic resistance, and disease progression. In this study, we present a single-cell transcriptomic dataset comprising 41 patient-derived cell cultures (PDCs) established from pancreatic ductal adenocarcinoma (PDAC). The dataset was generated using Evercode™ technology, which is based on Split Pool Ligation-based Transcriptome sequencing (SPLiT-seq). This scalable method enables high-throughput profiling across multiple samples without droplet-based microfluidics, allowing efficient capture of inter-sample heterogeneity. This functionally annotated collection of experimentally derived models reveals transcriptional heterogeneity both within and across PDCs, enabling in-depth exploration of PDAC cell diversity, to support the development of computational tools for single-cell analysis, and to guide functional studies on tumour cell subpopulations. This resource constitutes a valuable reference for computational and experimental studies aiming to decipher PDAC heterogeneity and identify therapeutic vulnerabilities.
No takes yet. Share an insight, caveat, or question.
Chocoloff et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: